claim: a prefusion sars-cov-2 spike rna vaccine is highly immunogenic and promotes lung infection in non-human primates
evidence_1: the bnt162b2 vaccine candidate fully protected the lungs of immunised rhesus macaques from infectious sars-cov-2 challenge.", "prime-boost vaccination of rhesus macaques elicited authentic sars- cov-2 neutralising geometric mean titers 10.2 to 18.0 times that of a sars- cov-2 convalescent human serum panel.", "in this study, we report the design, preclinical development, immunogenicity and anti-viral protective effect in rhesus macaques of the bnt162b2 vaccine candidate.")